Mortality and morbidity in different immunization protocols for experimental autoimmune myocarditis in rats

Acta Physiologica

Volumn 210, Issue 4, 2014, Pages 889-898

  Schmerler, P ^a   Jeuthe, S ^b   O h Ici, D ^b   Wassilew, K ^b   Lauer, D ^a   Kaschina, E ^a   Kintscher, U ^a   Muller S ^a   Muench, F ^b   Kuehne, T ^b   Berger, F ^b   Unger, T ^c   Steckelings, U M ^a,d   Paulis, L ^a,e   Messroghli, D ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e CARIM School for Cardiovascular Diseases Maastricht University ^*  (Slovakia)

Author keywords

Autoimmune myocarditis; Dilated cardiomyopathy; Inflammatory cardiomyopathy; Lewis rat; MRI

Indexed keywords

CARDIAC MYOSIN; CD68 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BODY COMPOSITION; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; CONTROLLED STUDY; DISTRESS SYNDROME; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; EXPERIMENTAL PIG; HEART CATHETERIZATION; HEART FUNCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MORBIDITY; MORTALITY; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN WEIGHT;

AUTOIMMUNE MYOCARDITIS; DILATED CARDIOMYOPATHY; INFLAMMATORY CARDIOMYOPATHY; LEWIS RAT; MRI;

ANIMALS; AUTOIMMUNE DISEASES; IMMUNIZATION; MALE; MYOCARDITIS; MYOCARDIUM; MYOSINS; RANDOM ALLOCATION; RATS; RATS, INBRED LEW;

EID: 84896044046     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12227     Document Type: Article

References (36)

1. Akashi, Y.J., Palus, S., Datta, R., Halem, H., Taylor, J.E., Thoene-Reineke, C., Dong, J., Thum, T., Culler, M.D., Anker, S.D. & Springer, J. 2009. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Int J Cardiol 137, 267-275.
2. Arumugam, S., Thandavarayan, R.A., Veeraveedu, P.T., Giridharan, V.V., Soetikno, V., Harima, M., Suzuki, K., Nagata, M., Tagaki, R., Kodama, M. & Watanabe, K. 2012a. Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant. Exp Mol Pathol 93, 183-189.
3. Arumugam, S., Thandavarayan, R.A., Veeraveedu, P.T., Ma, M., Giridharan, V.V., Arozal, W., Sari, F.R., Sukumaran, V., Lakshmanan, A., Soetikno, V., Suzuki, K., Kodama, M. & Watanabe, K. 2012b. Modulation of endoplasmic reticulum stress and cardiomyocyte apoptosis by mulberry leaf diet in experimental autoimmune myocarditis rats. J Clin Biochem Nutr 50, 139-144.
4. Cooper, L.T. Jr. 2009. Myocarditis. N Engl J Med 360, 1526-1538.
5. Feldman, A.M. & McNamara, D. 2000. Myocarditis. N Engl J Med 343, 1388-1398.
6. Felker, G.M., Jaeger, C.J., Klodas, E., Thiemann, D.R., Hare, J.M., Hruban, R.H., Kasper, E.K. & Baughman, K.L. 2000. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 140, 785-791.
7. Hirano, E., Shimada, K., Komiyama, T., Fujita, M. & Kishimoto, C. 2013. Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production. Int J Cardiol 167, 2228-2233.
8. Hirono, S., Islam, M.O., Nakazawa, M., Yoshida, Y., Kodama, M., Shibata, A., Izumi, T. & Imai, S. 1997. Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ Res 80, 11-20.
9. Hishikari, K., Watanabe, R., Ogawa, M., Suzuki, J., Masumura, M., Shimizu, T., Takayama, K., Hirata, Y., Nagai, R. & Isobe, M. 2010. Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity. Heart 96, 523-527.
10. Ishiyama, S., Hiroe, M., Nishikawa, T., Shimojo, T., Abe, S., Fujisaki, H., Ito, H., Yamakawa, K., Kobayashi, N., Kasajima, T. & Marumo, F. 1998. The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. J Immunol 161, 4695-4701.
11. Izumi, T., Kodama, M. & Shibata, A. 1991. Experimental giant cell myocarditis induced by cardiac myosin immunization. Eur Heart J 12(Suppl D), 166-168.
12. Kodama, M., Matsumoto, Y., Fujiwara, M., Masani, F., Izumi, T. & Shibata, A. 1990. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57, 250-262.
13. Kodama, M., Matsumoto, Y., Fujiwara, M., Zhang, S.S., Hanawa, H., Itoh, E., Tsuda, T., Izumi, T. & Shibata, A. 1991. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 69, 1042-1050.
14. Kodama, M., Hanawa, H., Zhang, S., Saeki, M., Koyama, S., Hosono, H., Miyakita, Y., Katoh, K., Inomata, T. & Izumi, T. 1993. FK506 therapy of experimental autoimmune myocarditis after onset of the disease. Am Heart J 126, 1385-1392.
15. Korkusuz, H., Esters, P., Naguib, N., Nour Eldin, N.-E., Lindemayr, S., Huebner, F., Koujan, A., Bug, R., Ackermann, H. & Vogl, T.J. 2009. Acute myocarditis in a rat model: late gadolinium enhancement with histopathological correlation. Eur Radiol 19, 2672-2678.
16. Korkusuz, H., Esters, P., Huebner, F., Bug, R., Ackermann, H. & Vogl, T.J. 2010. Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model. J Cardiovasc Magn Reson 12, 49.
17. Kromen, W., Korkusuz, H., Korkusuz, Y., Esters, P., Bauer, R.W., Huebner, F., Lindemayr, S. & Vogl, T.J. 2012. Correlation of left ventricular wall thickness, heart mass, serological parameters and late gadolinium enhancement in cardiovascular magnetic resonance imaging of myocardial inflammation in an experimental animal model of autoimmune myocarditis. Int J Cardiovasc Imaging 28, 1983-1997.
18. Leuschner, F., Katus, H.A. & Kaya, Z. 2009. Autoimmune myocarditis: past, present and future. J Autoimmun 33, 282-289.
19. Maeda, K., Shioi, T., Kosugi, R., Yoshida, Y., Takahashi, K., Machida, Y. & Izumi, T. 2005. Rapamycin ameliorates experimental autoimmune myocarditis. Int Heart J 46, 513-530.
20. Maisch, B., Richter, A., Sandmöller, A., Portig, I. & Pankuweit, S. 2005. Inflammatory dilated cardiomyopathy (DCMI). Herz 30, 535-544.
21. Mito, S., Watanabe, K., Harima, M., Thandavarayan, R.A., Veeraveedu, P.T., Sukumaran, V., Suzuki, K., Kodama, M. & Aizawa, Y. 2011. Curcumin ameliorates cardiac inflammation in rats with autoimmune myocarditis. Biol Pharm Bull 34, 974-979.
22. Moon, H., Park, H.E., Kang, J., Lee, H., Cheong, C., Lim, Y.T., Ihm, S.-H., Seung, K.-B., Jaffer, F.A., Narula, J., Chang, K. & Hong, K.S. 2012. Noninvasive assessment of myocardial inflammation by cardiovascular magnetic resonance in a rat model of experimental autoimmune myocarditis. Circulation 125, 2603-2612.
23. Obata, H., Yanagawa, B., Tanaka, K., Ohnishi, S., Kataoka, M., Miyahara, Y., Ishibashi-Ueda, H., Kodama, M., Aizawa, Y., Kangawa, K. & Nagaya, N. 2007. CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis. Biochem Biophys Res Commun 356, 60-66.
24. Otsuka, K., Terasaki, F., Ikemoto, M., Fujita, S., Tsukada, B., Katashima, T., Kanzaki, Y., Sohmiya, K., Kono, T., Toko, H., Fujita, M. & Kitaura, Y. 2009. Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network. Eur J Heart Fail 11, 229-237.
25. Persson, P.B. 2013. Good publication practice in physiology 2013: revised author guidelines for Acta Physiologica. Acta Physiol (Oxf) 209, 250-253.
26. Saito, J., Niwano, S., Niwano, H., Inomata, T., Yumoto, Y., Ikeda, K., Inuo, K., Kojima, J., Horie, M. & Izumi, T. 2002. Electrical remodeling of the ventricular myocardium in myocarditis: studies of rat experimental autoimmune myocarditis. Circ J 66, 97-103.
27. Sato, M., Toyozaki, T., Odaka, K., Uehara, T., Arano, Y., Hasegawa, H., Yoshida, K., Imanaka-Yoshida, K., Yoshida, T., Hiroe, M., Tadokoro, H., Irie, T., Tanada, S. & Komuro, I. 2002. Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C. Circulation 106, 1397-1402.
28. Smith, S.C. 2001. Autoimmune myocarditis. Curr Protoc Immunol (Suppl 31), 1-19. Chapter 15, Unit 15.14.
29. Song, Z.-C., Wang, Z.-S., Bai, J.-H., Li, Z. & Hu, J. 2012. Emodin, a naturally occurring anthraquinone, ameliorates experimental autoimmune myocarditis in rats. Tohoku J Exp Med 227, 225-230.
30. Sukumaran, V., Veeraveedu, P.T., Gurusamy, N., Lakshmanan, A.P., Yamaguchi, K., Ma, M., Suzuki, K., Kodama, M. & Watanabe, K. 2012. Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis. Life Sci 90, 289-300.
31. Suzuki, J., Ogawa, M., Muto, S., Itai, A. & Isobe, M. 2008. A specific inhibitor of plasminogen activator inhibitor-1 suppresses rat autoimmune myocarditis. Expert Opin Ther Targets 12, 1313-1320.
32. Veeraveedu, P.T., Watanabe, K., Ma, M., Palaniyandi, S.S., Yamaguchi, K., Kodama, M. & Aizawa, Y. 2008a. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Biochem Pharmacol 75, 1322-1330.
33. Veeraveedu, P.T., Watanabe, K., Ma, M., Palaniyandi, S.S., Yamaguchi, K., Suzuki, K., Kodama, M. & Aizawa, Y. 2008b. Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Eur J Pharmacol 581, 121-131.
34. Wakisaka, Y., Niwano, S., Niwano, H., Saito, J., Yoshida, T., Hirasawa, S., Kawada, H. & Izumi, T. 2004. Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. Cardiovasc Res 63, 689-699.
35. Yoshida, Y., Shioi, T. & Izumi, T. 2007. Resveratrol ameliorates experimental autoimmune myocarditis. Circ J 71, 397-404.
36. Yuan, Z., Liu, Y., Liu, Y., Zhang, J., Kishimoto, C., Ma, A. & Liu, Z. 2004. Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. J Cardiovasc Pharmacol 43, 868-875.